Nano-X Imaging (NASDAQ:NNOX) CEO Acquires $33,480.00 in Stock

Nano-X Imaging Ltd. (NASDAQ:NNOX) CEO Erez Meltzer acquired 36,000 shares of the stock in a transaction dated Monday, July 27th. The stock was acquired at an average price of $0.93 per share, with a total value of $33,480.00. Following the completion of the acquisition, the chief executive officer owned 36,000 shares in the company, valued at approximately $33,480. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Nano-X Imaging Stock Performance

Shares of Nano-X Imaging stock opened at $0.96 on Friday. Nano-X Imaging Ltd. has a 52-week low of $0.73 and a 52-week high of $4.95. The company has a fifty day moving average of $1.43 and a 200-day moving average of $2.05. The stock has a market capitalization of $67.16 million, a price-to-earnings ratio of -0.61 and a beta of 1.24.

Nano-X Imaging (NASDAQ:NNOX) last issued its earnings results on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The business had revenue of $4.31 million during the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%. On average, equities research analysts forecast that Nano-X Imaging Ltd. will post -0.6 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nano-X Imaging

A number of hedge funds have recently modified their holdings of NNOX. Kestra Advisory Services LLC purchased a new position in shares of Nano-X Imaging in the first quarter valued at about $26,000. Independent Financial Group LLC purchased a new stake in shares of Nano-X Imaging during the first quarter worth about $26,000. Interchange Capital Partners LLC bought a new stake in shares of Nano-X Imaging in the fourth quarter worth about $28,000. Aristides Capital LLC bought a new stake in shares of Nano-X Imaging in the fourth quarter worth about $30,000. Finally, Hsbc Holdings PLC purchased a new position in Nano-X Imaging during the 1st quarter valued at about $35,000. Hedge funds and other institutional investors own 21.49% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on NNOX shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. Zacks Research upgraded Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Alliance Global Partners cut Nano-X Imaging from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, D. Boral Capital reiterated a “buy” rating and issued a $5.00 price objective on shares of Nano-X Imaging in a research report on Monday, April 20th. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Nano-X Imaging has a consensus rating of “Moderate Buy” and a consensus target price of $4.00.

Trending Headlines about Nano-X Imaging

Here are the key news stories impacting Nano-X Imaging this week:

• Positive Sentiment: CEO Erez Meltzer bought 36,000 shares at an average price of $0.93, while Director Dan S. Suesskind purchased 50,000 shares at the same price. The combined $79,980 in insider buying may signal that company leadership views NNOX’s depressed valuation as attractive, although the purchases are modest relative to the company’s risks. CEO insider purchase filing Director insider purchase filing
• Neutral Sentiment: Investors are preparing for Nano-X Imaging’s Q2 2026 earnings release. The preview provides an upcoming catalyst, but no new financial results or guidance were included in the report. The market will likely focus on revenue growth, cash burn, operating expenses and progress with the Nanox.ARC imaging platform. Nano-X Imaging Q2 2026 earnings preview
• Negative Sentiment: Bronstein Gewirtz & Grossman and Glancy Prongay Wolke & Rotter announced or promoted a securities class action against NNOX and certain officers. The allegations involve potentially misleading disclosures about cash burn and operating expenses before a reported $17.5 million impairment and manufacturing restructuring. The claims have not been proven, but potential legal costs, reputational damage and uncertainty may pressure the stock. Bronstein class action announcement Glancy class action announcement
• Neutral Sentiment: Several law firms reminded investors of an August 11, 2026 deadline to seek lead-plaintiff status. These notices are primarily legal-firm solicitations rather than new company developments, but their frequency keeps the litigation in focus. Rosen deadline notice

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.